miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer

FEBS Letters

Volumn 589, Issue 7, 2015, Pages 812-821

  Hui, Zeng ^a   Yiling, Chen ^b   Wenting, You ^b   Xuqun, Huang ^c   Chuanyi, Zhou ^d   Hui, Li ^b  

^a JIANGHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Huangshi Center Hospital of Hubei Province   (China)

^d Department of Radiation Oncology Yueyang Second People's Hospital ^*  (China)

Author keywords

Breast cancer; Estrogen receptor ; Estrogen signaling; JMJD2B; miR 491 5p

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HISTONE DEMETHYLASE; MICRORNA; MICRORNA 491 5P; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AZACITIDINE; DECITABINE; KDM4B PROTEIN, HUMAN; MIRN491 MICRORNA, HUMAN;

ADULT; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG TARGETING; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; 3' UNTRANSLATED REGION; AGED; ANALOGS AND DERIVATIVES; BREAST TUMOR; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADULT; AGED; AZACITIDINE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MCF-7 CELLS; MICRORNAS; MIDDLE AGED;

EID: 84925486579     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.02.014     Document Type: Article

References (39)

1. M.P. McCafferty, R.E. McNeill, N. Miller, and M.J. Kerin Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer Breast Cancer Res. Treat. 116 2009 425 432
2. S. Ali, L. Buluwela, R. Coombes, and C. Caskey Antiestrogens and their therapeutic applications in breast cancer and other diseases Annu. Rev. Med. 62 2011 217 232
3. C. Davies, J. Godwin, R. Gray, M. Clarke, and D. Cutter et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 2011 771 784
4. J.C. Black, C. Van Rechem, and J.R. Whetstine Histone lysine methylation dynamics: establishment, regulation, and biological impact Mol. Cell 48 2012 491 507
5. M. Albert, and K. Helin Histone methyltransferases in cancer Semin. Cell Dev. Biol. 21 2010 209 220
6. J.R. Whetstine, A. Nottke, F. Lan, M. Huarte, and S. Smolikov et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases Cell 125 2006 467 481
7. W.L. Berry, and R. Janknecht KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells Cancer Res. 73 2013 2936 2942
8. L. Gaughan, J. Stockley, K. Coffey, D. O'Neill, and D.L. Jones et al. KDM4B is a master regulator of the estrogen receptor signalling cascade Nucleic Acids Res. 41 14 2013 Aug 6892 6904
9. K. Coffey, L. Rogerson, C. Ryan-Munden, D. Alkharaif, and J. Stockley et al. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover Nucleic Acids Res. 41 2013 4433 4446
10. M. Kawazu, K. Saso, K.I. Tong, T. McQuire, and K. Goto et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development PLoS ONE 6 2011 e17830
11. J. Yang, A.M. Jubb, L. Pike, F.M. Buffa, and H. Turley et al. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth Cancer Res. 70 2010 6456 6466
12. J. Krol, I. Loedige, and W. Filipowicz The widespread regulation of microRNA biogenesis, function and decay Nat. Rev. Genet. 11 2010 597 610
13. A. Esquela-Kerscher, and F.J. Slack Oncomirs: microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
14. S. Volinia, M. Galasso, M.E. Sana, T.F. Wise, and J. Palatini et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA Proc. Natl. Acad. Sci. U.S.A. 109 2012 3024 3029
15. A. Feliciano, J. Castellvi, A. Artero-Castro, J.A. Leal, and C. Romagosa et al. MiR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9 PLoS ONE 8 2013 e76247
16. N. Kondo, T. Toyama, H. Sugiura, Y. Fujii, and H. Yamashita MiR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer Cancer Res. 68 2008 5004 5008
17. D.P. Pandey, and D. Picard MiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA Mol. Cell. Biol. 29 2009 3783 3790
18. N. Yoshimoto, T. Toyama, S. Takahashi, H. Sugiura, and Y. Endo et al. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer Breast Cancer Res. Treat. 130 2011 331 339
19. F. Rothé, M. Ignatiadis, C. Chaboteaux, B. Haibe-Kains, and N. Kheddoumi et al. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer PLoS ONE 6 2011 e20980
20. W.C. Huang, S.H. Chan, T.H. Jang, J.W. Chang, and Y.C. Ko et al. MiRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis Cancer Res. 74 2014 751 764
21. Y. Zhou, Y. Li, J. Ye, R. Jiang, and H. Yan et al. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition Liver Int. 33 2013 1271 1280
22. R. Guo, Y. Wang, W.Y. Shi, B. Liu, S.Q. Hou, and L. Liu MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway Molecules 17 2012 14733 14747
23. C. Denoyelle, B. Lambert, M. Meryet-Figuière, N. Vigneron, and E. Brotin et al. MiR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation Cell Death Dis. 5 2014 e1445
24. N. Wang, Y. Zhou, L. Zheng, and H. Li MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A Gynecol. Oncol. 134 2014 129 137
25. N. Wang, T. Zhan, T. Ke, X. Huang, D. Ke, Q. Wang, and H. Li Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer Br. J. Cancer 110 2014 1034 1044
26. X. Wang, F. Jiang, J. Mu, X. Ye, and L. Si et al. Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491 Toxicol. Lett. 227 2014 75 83
27. L. Mulrane, R. Klinger, S.F. McGee, W.M. Gallagher, and D.P. O'Connor MicroRNAs: a new class of breast cancer biomarkers Expert Rev. Mol. Diagn. 14 2014 347 363
28. X. Li, R. Sun, W. Chen, B. Lu, and X. Li et al. A systematic in silico mining of the mechanistic implications and therapeutic potentials of estrogen receptor (ER)-α in breast cancer PLoS ONE 9 2014 e91894
29. H. Dvinge, A. Git, S. Graf, M. Salmon-Divon, and C. Curtis et al. The shaping and functional consequences of the microRNA landscape in breast cancer Nature 497 2013 378 382
30. S.K. Leivonen, K.K. Sahlberg, R. Mäkelä, E.U. Due, and O. Kallioniemi et al. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth Mol. Oncol. 8 2014 93 104
31. L. Shi, L. Sun, Q. Li, J. Liang, and W. Yu et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis Proc. Natl. Acad. Sci. U.S.A. 108 2011 7541 7546
32. S.F. Doisneau-Sixou, C.M. Sergio, J.S. Carroll, R. Hui, E.A. Musgrove, and R.L. Sutherland Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells Endocr. Relat. Cancer 10 2003 179 186
33. A. Hossain, M.T. Kuo, and G.F. Saunders Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA Mol. Cell. Biol. 26 2006 8191 8201
34. B.D. Adams, D.M. Cowee, and B.A. White The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells Mol. Endocrinol. 23 2009 1215 1230
35. W. Zwart, A. Griekspoor, M. Rondaij, D. Verwoerd, and J. Neefjes et al. Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor α Mol. Cancer Ther. 6 2007 1526 1533
36. S.R. Johnston, G. Saccani-Jotti, I.E. Smith, J. Salter, and J. Newby et al. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer Cancer Res. 55 1995 3331 3338
37. J. Cui, M. Bi, A. Overstreet, Y. Yang, and H. Li et al. MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells Oncogene 2014 10.1038/onc.2014.430 [Epub ahead of print]
38. P. de Souza Rocha Simonini, A. Breiling, N. Gupta, M. Malekpour, and M. Youns et al. Deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells Cancer Res. 70 2010 9175 9184
39. Y.M. Lee, J.Y. Lee, C.C. Ho, Q.S. Hong, and S.L. Yu MiRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells Breast Cancer Res. 13 2011 R116